Related by context. All words. (Click for frequent words.) 66 pancreatic adenocarcinoma 65 HNSCC 65 lung adenocarcinomas 65 hepatocellular carcinoma HCC 65 familial pancreatic cancer 65 MSH2 65 nonsmall cell lung cancer 65 atypical hyperplasia 65 BRAF gene 65 mutated BRCA1 65 cisplatin resistant 64 prostate cancer CaP 64 bladder cancers 64 BRAF mutation 64 gastrointestinal stromal tumors GISTs 64 serous ovarian cancer 64 GISTs 64 squamous cell lung cancer 64 colorectal carcinoma 64 K ras mutations 64 basal cell carcinoma BCC 64 breast pancreatic 64 malignant pleural mesothelioma 64 ABCB1 63 invasive ductal 63 TCF#L# gene 63 familial ALS 63 KRAS oncogene 63 prostate carcinoma 63 epithelial tumors 63 lung tumors 63 FGFR2 63 BRCA2 gene mutation 63 histologies 63 ADPKD 63 WT1 63 breast cancer genes BRCA1 63 TP# mutation 63 GBM tumors 63 renal cell carcinomas 63 chromosomal rearrangement 62 CYP#C# [001] 62 mutated K ras 62 NSCLC tumors 62 adenocarcinomas 62 p# mutations 62 microdeletions 62 gastric cancers 62 PCa 62 HER2 positive cancers 62 CHEK2 62 HNPCC 62 CYP#D# gene 62 MTHFR 62 Squamous 62 medulloblastomas 62 MGUS 62 EGFR mutation 62 seminoma 62 endometrial cancers 62 SOD1 gene 62 MYH9 gene 62 esophageal squamous cell carcinoma 62 neuroendocrine cancers 62 BRCA1 BRCA2 62 colorectal cancer CRC 62 mesotheliomas 62 breast carcinoma 62 monogenic 61 PARP inhibition 61 testicular germ cell 61 molecular abnormalities 61 ductal breast cancer 61 myeloproliferative disorders 61 MTHFR gene 61 osteosarcomas 61 breast carcinomas 61 APOE e4 61 basal cell nevus syndrome 61 sarcomatoid 61 urothelial cancer 61 neuroblastoma tumors 61 adenocarcinoma 61 HER2 overexpression 61 mtDNA mutations 61 KRAS mutation 61 GPC5 61 Epstein Barr virus EBV 61 KRAS mutations 61 VKORC1 61 gefitinib Iressa 61 EGFR gene 61 pilocytic astrocytomas 61 carcinoid 61 testicular cancers 61 NF1 61 narcolepsy cataplexy 61 metaplasia 61 ApoE4 61 nonsense mutations 61 BRCA mutations 61 lobular carcinoma 61 lobular breast cancer 61 Her2/neu 61 malignant lymphomas 61 advanced adenomas 61 lung carcinomas 61 ALK mutations 61 colorectal adenoma 61 susceptibility loci 61 telomere lengths 61 prostate adenocarcinoma 61 colorectal polyps 61 anaplastic lymphoma kinase 61 susceptibility gene 61 epithelial cancers 61 LRRK2 gene 61 nodal metastasis 61 LQTS 61 histologic subtype 61 neurofibromas 61 non coding RNA 61 genetic variants associated 60 somatic mutations 60 invasive lobular 60 nonmelanoma skin cancers 60 FLT3 60 familial adenomatous polyposis 60 lung cancer NSCLC 60 AML MDS 60 nonmelanoma skin cancer 60 subependymal giant cell 60 colorectal cancers 60 gene BRCA2 60 Gleevec resistant 60 EGFR tyrosine kinase inhibitors 60 Leukemias 60 prostate pancreatic 60 lung cancers 60 endometrial hyperplasia 60 metastatic gastric 60 gastric carcinoma 60 LRP5 60 genetic polymorphisms 60 genes CYP#C# 60 KIF6 gene 60 APOL1 60 PTPN# 60 ALK inhibitors 60 CYP#C# [002] 60 pheochromocytoma 60 paraganglioma 60 HER2 expression 60 germline mutations 60 malignant lymphoma 60 bladder tumors 60 prognostic markers 60 AAT deficiency 60 aneuploidy 60 papillary renal cell carcinoma 60 molecular subtypes 60 CDKN2A 60 grade gliomas 60 Gorlin syndrome 60 Hurthle cell 60 sporadic ALS 60 chemoresistant 60 Hepatocellular Carcinoma HCC 60 activating mutation 60 ovarian breast 60 BRAF mutations 60 pleural mesothelioma 60 TCF#L# 60 promoter hypermethylation 60 hypermethylated 60 eIF 4E 60 proto oncogene 60 PIK3CA 60 mucinous 60 BARD1 60 hormone receptor negative 60 skeletal metastases 60 C#Y 60 gene rearrangements 60 PTEN mutations 60 aneuploidies 60 breast cancer subtypes 60 castration resistant 60 miRNA expression 60 Leydig cell 60 FTLD 60 renal carcinoma 60 epigenetic mechanisms 59 herpesviruses 59 chromosomal abnormalities 59 premalignant 59 monozygotic twin 59 ovarian cancers 59 IDH1 59 VIPR2 59 EGFR mutations 59 ovarian pancreatic 59 hepatoma 59 BRCA1 mutations 59 non squamous 59 diagnostic biomarker 59 BRCA1 mutation 59 bowel cancers 59 imatinib resistance 59 myelofibrosis polycythemia vera 59 EGFR protein 59 APOE ε4 59 BRCA2 mutation carriers 59 epithelial ovarian cancer 59 situ LCIS 59 PARP inhibitors 59 tumor subtypes 59 malignancies 59 CDH1 59 acute myelogenous leukemia AML 59 BRCA2 gene 59 #q# deletion 59 Basal cell 59 HPV# 59 BRCA2 mutations 59 ERBB2 59 rs# [002] 59 pulmonary metastases 59 IgA deficiency 59 CC genotype 59 genetic syndromes 59 SNP rs# [001] 59 epigenetic modification 59 DNA methylation patterns 59 myeloproliferative diseases 59 genetic aberrations 59 chromosomal aberrations 59 colorectal gastric 59 estrogen receptor negative 59 inherited mutations 59 nasopharyngeal cancer 59 neurofibromatosis type 59 intestinal polyps 59 NKX#.# 59 premalignant lesions 59 lipid abnormalities 59 apolipoprotein E gene 59 microcephalin 59 familial hypercholesterolemia 59 prostate cancer PCa 59 carcinoid tumors 59 lymphomas 59 #q#.# [001] 59 thyrotropin levels 59 Uterine cancer 59 metastatic colorectal 59 GBMs 59 alpha1 antitrypsin deficiency 59 GSTP1 59 rs# [001] 59 postmenopausal breast cancer 59 activating mutations 59 invasive lobular carcinoma 59 apoptotic pathway 59 MLL2 59 crystallin 59 CYP#B# 59 IDH1 mutation 59 CYT# potent vascular disrupting 59 thalidomide Thalomid 59 aneuploid cells 59 modifier genes 59 pancreatic endocrine 59 HbF 59 hepatocellular carcinomas 59 histone deacetylases 59 macroalbuminuria 59 Fas ligand 59 radiosensitive 59 SOD2 gene 59 T1D 59 untreated celiac disease 59 micrometastases 59 BRAF V#E 59 cell carcinomas 59 flavopiridol 59 TMEM#B 59 BRCA2 gene mutations 59 prostate cancers 59 TTR gene 59 urothelial carcinoma 58 AGTR1 58 primary biliary cirrhosis 58 Fragile X gene 58 TP# gene 58 colorectal neoplasia 58 metastatic neuroendocrine tumors 58 NF2 58 CDK4 58 miRNA genes 58 Hashimoto thyroiditis 58 TMPRSS2 ERG 58 UGT#A# * 58 hyperplastic 58 MAPK pathway 58 T#I [002] 58 Papillary 58 colorectal polyp 58 breast cancers 58 NFkB 58 Waldenstrom macroglobulinemia 58 pancreatic cancers 58 atherosclerotic lesions 58 breast endometrial 58 thyroid tumors 58 MC1R gene 58 missense mutation 58 histological subtype 58 MC1R 58 TP# mutations 58 hepatocellular carcinoma 58 rs# [003] 58 generalized vitiligo 58 medullary thyroid cancer 58 alpha1 antitrypsin AAT deficiency 58 STAT4 58 c KIT 58 leiomyoma 58 microarray experiments 58 Lung transplantation 58 colorectal tumors 58 1 diabetes T1D 58 ductal carcinomas 58 systemic lupus erythematosus SLE 58 Glioblastomas 58 LHRH receptor positive 58 mammary cells 58 missense mutations 58 invasive cervical cancer 58 leukemia CLL 58 sCJD 58 NSCLC 58 motor neuron degeneration 58 Malignant mesothelioma 58 MLH1 58 micronuclei 58 Li Fraumeni 58 anti angiogenic therapy 58 SSc 58 genes BRCA1 58 grade cervical intraepithelial 58 astrocytomas 58 GIST tumors 58 chromosomal mutations 58 basal cell carcinomas 58 haematopoietic 58 SORL1 gene 58 GNAQ 58 HLA B# 58 PALB2 58 breast epithelial cells 58 DFMO 58 imatinib Gleevec 58 serum biomarkers 58 promoter methylation 58 chromosomal instability 58 ApoE4 gene 58 kidney urologic 58 breast tumors 58 papillary carcinoma 58 druggable targets 58 leukaemias 58 hamartomas 58 Renal Cell Carcinoma RCC 58 tumor histology 58 HCV infection 58 squamous 58 HER2 receptor 58 gastric adenocarcinoma 58 colon carcinoma 58 HER2 neu 58 castrate resistant 58 HLA DRB1 58 BRCA1 gene 58 operable breast cancer 58 transgene expression 58 ErbB2 positive 58 Dr. Victor Velculescu 58 BRCA2 mutation 58 Cryptococcus neoformans 58 PCNSL 58 T1DM 58 precursor lesions 58 Colon polyps 58 variant allele 58 gastrointestinal cancers 58 PDGFR 58 uveal melanoma 58 HER2 positive breast 58 EGFR pathway 58 TGFBR1 * 6A 58 ccRCC 58 primary cilia 58 NAFLD 58 myeloproliferative 58 NOMID 58 OGG1 58 chromosomal deletions 58 gene fusions 58 Cholangiocarcinoma 58 clade B 58 invasive ductal carcinomas 58 metachronous 58 ADAMTS# 58 EGFR inhibitors 58 histologic subtypes 58 tarenflurbil 58 COX2 58 de novo mutations 58 Epstein Barr Virus EBV 58 differentiated thyroid 58 KRAS mutant 58 elevated triglyceride levels 58 ALK gene 58 gene variants 58 microdeletion 58 lysosomal storage diseases 58 beta1 integrin 58 Trichomonas vaginalis 58 immunocompetent 58 ductal cancer 58 adenomatous 57 colorectal tumor 57 gene mutations 57 cancers 57 neuroblastomas 57 Glucocorticoids 57 ERK signaling 57 Gastric cancer 57 lung pancreatic 57 micro RNAs 57 BRCA gene mutation 57 histone deacetylase inhibitors 57 Genetic variants 57 rs# [004] 57 CIN2 + 57 hypermethylation 57 Stat5 57 endostatin 57 ApoE gene 57 Immunohistochemical analysis 57 colon tumors 57 cutaneous melanoma 57 CYP#C# gene 57 dysglycemia 57 NPM1 57 ADAM# 57 lymphocytic 57 pancreatic lung 57 Prostatitis 57 APOE4 57 mutated genes 57 lymphoid tumors 57 invasive ductal breast cancer 57 xenograft tumors 57 syngeneic 57 TPMT 57 ependymomas 57 colorectal liver metastases 57 hereditary predisposition 57 neoplasias 57 single nucleotide polymorphism 57 benign neoplasms 57 IL#B 57 oesophageal squamous cell carcinoma 57 ovarian endometrial 57 microRNA expression 57 micro RNA 57 autoantibody 57 tumors 57 vinca alkaloids 57 vWD 57 mycosis fungoides 57 advanced neoplasia 57 Bcr Abl 57 Chronic lymphocytic leukemia 57 nasopharyngeal carcinoma 57 lymphoproliferative disorders 57 liver metastasis 57 causal variants 57 HER2/neu 57 mutations 57 commonly mutated genes 57 lobular 57 T2DM 57 diabetes mellitus DM 57 somatic mutation 57 adenoma 57 unresectable tumors 57 metastatic tumors 57 splice variants 57 JAK2 enzyme 57 renal tumors 57 heterozygotes 57 adenomatous polyps 57 K ras gene 57 gliomas 57 geographic atrophy 57 Estrogen Receptor 57 MLL gene 57 N Myc 57 protein tyrosine phosphatase 57 sorafenib Nexavar 57 benign proliferative breast 57 Niemann Pick disease 57 unmutated 57 LRRK2 mutation 57 abnormal cytology 57 macrovascular events 57 CFTR gene 57 genetic loci 57 hematopoietic malignancies 57 cervical carcinoma 57 frequently benign tumor 57 gene APOE4 57 poorer prognosis 57 PKCi 57 genetic variants 57 HER2 gene 57 metastatic lung cancer 57 Endometrial cancer 57 monocytic 57 tumor xenograft models 57 trophoblast cells 57 HIV HCV coinfected 57 RRM1 57 oncogenic mutations 57 ovarian lung 57 androgen receptor gene 57 extramedullary 57 dyskeratosis congenita 57 prognostic marker 57 Gliomas 57 cyclin E 57 Carcinoid tumors 57 ovarian tumors 57 circulating endothelial cells 57 K ras 57 pancreatic prostate 57 UGT#A# 57 Aviptadil 57 LPA gene 57 COL#A# 57 TT genotype 57 bladder ovarian 57 BRCA mutation carriers 57 erlotinib Tarceva 57 methylation patterns 57 colorectal carcinogenesis 57 medulloblastoma 57 germline mutation 57 gastrointestinal GI cancers 57 leiomyomas 57 intravenous bisphosphonates 57 neoplasm 57 MAGE A3 protein 57 synthetic lethality 57 allogeneic HSCT 57 gene mutation 57 Chronic Lymphocytic Leukemia CLL 57 Genetic variation 57 CALHM1 57 genetic variant 57 bronchogenic carcinoma 57 HGPIN 57 MetS 57 EoE 57 K#R [002] 57 NF kB pathway 57 cholangiocarcinoma 57 allelic variants 57 BCL#A 57 motor neuron diseases 57 pancreatic neuroendocrine tumors 57 PITX2 57 epithelioid 57 carcinomas 57 IL#R 57 Haptoglobin 57 FGFR1 57 Raf MEK ERK 57 human leukocyte antigens 57 ductal lobular 57 chromosomal alterations 57 MAP#K# 57 LRAT 57 vimentin 57 Smac mimetic 57 chromosome #p#.# 57 antiestrogen 57 parkin gene 57 apolipoprotein E4 57 tumor subtype 57 gene amplification 57 myeloproliferative neoplasms 57 mammary tumors 57 chlamydial infection 57 c MET 57 MMP# 57 MDR1 57 ovarian carcinoma 57 MC4R gene 56 transthyretin amyloidosis 56 gamma secretase inhibitor 56 EGFR mutant 56 pancreatic islet cell 56 gefitinib 56 interferon IFN 56 urethritis 56 meningiomas 56 dopamine receptor gene 56 carcinoids 56 gene APOE 56 mitochondrial DNA mtDNA 56 pheochromocytomas 56 ERCC1 56 malignant transformation 56 endocrine tumors 56 HOTAIR 56 cardioembolic stroke 56 chromosomal anomalies 56 hematologic disorders 56 hypereosinophilic syndrome 56 leukemias lymphomas 56 ALI ARDS 56 paricalcitol 56 transgenic rats 56 MeCP2 gene 56 methylation markers 56 mammary cancers 56 pancreatic ovarian 56 myeloid 56 p#INK#a 56 luminal cells 56 untreated metastatic melanoma 56 ductal adenocarcinoma 56 lung carcinoma 56 synovial cells 56 Adjuvant chemotherapy 56 PD# [005] 56 HepG2 cells 56 differentially expressed genes 56 p# mutation 56 CYP#A# gene 56 NNRTI resistance 56 relapsed ovarian cancer 56 Sezary syndrome 56 bexarotene 56 Acute myeloid leukemia 56 HMGA2 56 GSTM1 56 CD#c 56 androgen independent 56 cerebral infarction 56 E selectin 56 oncogenes 56 SORL1 56 juvenile idiopathic arthritis JIA 56 mitochondrial disorders 56 histological subtypes 56 squamous cell carcinoma SCC 56 glioblastoma tumors 56 myeloma cells 56 microRNA molecules 56 TNF blocker therapy 56 KIT mutations 56 immunohistochemical 56 PDE#A 56 pathogenic mutations 56 tumor suppressor genes 56 systemic amyloidosis 56 estrogen receptor ER 56 hormone receptor positive 56 colorectal cancer 56 oligodendrogliomas 56 microRNA miR 56 xenograft models 56 Kufs disease 56 drug metabolizing enzymes 56 malignant prostate 56 HLA molecules 56 childhood leukemias 56 gallstone disease 56 NRTI resistance 56 gynecologic malignancy 56 LDL receptor 56 hereditary hemochromatosis 56 chronic HBV 56 precancerous cervical lesions 56 breast cancer metastasis 56 Squamous cell 56 multivariate logistic regression 56 2 diabetes T2D 56 thrombophilia 56 supratentorial 56 gastrointestinal stromal tumors 56 basal cells 56 INTERHEART study 56 pancreatic islet 56 inherited predisposition 56 gastric carcinogenesis 56 breast ovarian 56 APOE gene 56 non coding RNAs 56 EGFR HER2 56 autoantibodies 56 atherothrombotic disease 56 nonalcoholic steatohepatitis NASH 56 Zolinza 56 APOC3 56 inactive X chromosome 56 BMP2 56 GBA mutations 56 chromosome translocations 56 epigenetic markers 56 GSTT1 56 castrate resistant prostate cancer 56 HMGCR 56 homozygotes 56 caveolin 1 56 transferrin saturation 56 invasive carcinoma 56 MAGE A3 56 PTEN gene 56 colorectal adenomas 56 alkylating agent 56 HER2 positive breast cancer 56 p# activation 56 BRIP1 56 oesophageal adenocarcinoma 56 SLC#A# [001] 56 anaplastic 56 vinca alkaloid 56 neuroendocrine carcinoma 56 sarcosine 56 HBeAg negative 56 seminomas 56 TACI mutations 56 CCR5 delta# 56 BRCA mutation 56 mutant BRAF 56 EGF receptor 56 Hodgkin lymphoma HL 56 SATB1 56 node metastases 56 genomic alterations 56 iNOS 56 malignant neoplasm 56 mosaicism 56 Endometrial 56 thyroid carcinoma 56 castration resistant prostate cancer 56 squamous cell 56 malignant pleural mesothelioma MPM 56 heterotaxy 56 T2D 56 androgen receptor AR 56 Myelodysplastic syndromes MDS 56 benign moles 56 erlotinib Tarceva ® 56 VHL gene 56 cystatin C 56 molecularly targeted 56 BRCA2 carriers 56 M. pneumoniae 56 progressive neurodegenerative disorder 56 squamous cell cancers 56 ZNF# 56 etiologic agent 56 MEF2A 56 normal karyotype 56 breast cancer gene mutation 56 PARP inhibitor 56 invasive carcinomas 56 STK# [002] 56 endoglin 56 undergone radical prostatectomy 56 CagA 56 TTR amyloidosis 56 NMIBC 56 chemoresistance 56 PAOD 56 lobular carcinomas 56 granzyme B 56 clinically insignificant 56 gene polymorphism 56 Relapsing remitting MS 56 Brain metastases 56 G6PD deficiency 56 curable cancers 56 TLR3 56 urothelial bladder cancer 56 colorectal neoplasms 56 gene expression patterns 56 tumor suppressor gene 56 tyrosine kinase inhibitors 56 cutaneous squamous cell carcinoma 56 leukemia AML 56 BCR ABL mutations 56 trophoblasts 56 EGFRvIII 56 postoperative delirium 56 uterine ovarian 56 metastatic renal cell carcinoma 56 papillary RCC 56 lymphoid cells 56 commercialize deforolimus 56 podocytes 56 chromosomal translocations 56 causative mutations 56 ErbB2 56 methylenetetrahydrofolate reductase 56 intestinal metaplasia 56 stratifying patients 56 K RAS 56 JAK mutations 56 axillary lymph nodes 56 MALT lymphoma 56 oropharyngeal cancer 56 chemokine receptor 56 olaparib 56 bronchial epithelial cells 56 ANCA associated 56 Rectal cancer 56 nonmelanoma 56 airway hyperresponsiveness 56 DLC1 56 superficial bladder cancer 56 ependymoma 56 Candida infection 55 Heterozygous 55 HIVAN 55 M. genitalium 55 neuroendocrine tumors 55 atherosclerotic disease 55 anemias 55 lymphoid malignancies 55 colorectal lung 55 MMP inhibitors 55 pDC 55 ORMDL3 55 TOMM# 55 glioblastomas 55 MIF protein 55 glioblastoma 55 CYP#D# 55 KRAS status 55 CISH 55 ALDH2 55 Colorectal cancer CRC 55 chromosome #q# [001] 55 klotho 55 stage IIIA 55 mRNA transcripts 55 prolonged QT interval 55 thyroid carcinomas 55 peritoneal carcinomatosis 55 G#S mutation 55 #p# [001] 55 colorectal adenocarcinoma 55 overexpress 55 cell lymphoma ALCL 55 epigenetic silencing 55 glioma tumors 55 Chronic HCV 55 coding genes 55 relapsed ALL 55 Kabuki syndrome 55 predictive biomarkers 55 p# biomarker 55 DRD2 55 DNA rearrangements 55 lichen planus 55 Aurora kinase 55 multifactorial disease 55 Helicobacter 55 adenomatous polyp 55 SMAD4 55 endometriosis ovarian cysts 55 EGF receptors 55 oncogenic transformation 55 lymphocytic leukemia 55 trastuzumab Herceptin ® 55 precancer 55 #p# [003] 55 antiproliferative effects 55 humanized monoclonal antibodies 55 oral squamous cell 55 tumor suppressor protein 55 inhibitory receptor 55 Carcinoma 55 papillomas 55 LV dysfunction 55 Chronic Myelogenous Leukemia CML 55 penile cancers 55 CP CPPS 55 cryptococcosis 55 T2 lesions 55 AEG# 55 N. gonorrhoeae 55 GRNOPC1 contains 55 prognostic indicator 55 SHANK3 55 varicoceles 55 nucleoside analogues 55 Epidermal Growth Factor Receptor 55 Kit CD# positive 55 recurrent glioblastoma multiforme 55 Peutz Jeghers syndrome 55 invasive breast cancer 55 adrenocortical cancer 55 gene locus 55 salpingo oophorectomy 55 causative genes 55 ENPP1 55 RIP1 55 carcinoembryonic antigen 55 deCODE BreastCancer TM 55 MEK inhibitors 55 EGFr 55 MYH9 55 apolipoproteins 55 Chlamydia trachomatis 55 cell adhesion molecule 55 FGFR2 gene 55 KIAA# 55 diagnostic biomarkers 55 microvascular disease 55 UVB induced 55 Basal Cell 55 muscular dystrophies 55 VEGF receptor 55 V#F mutation 55 cervical breast 55 homozygous familial hypercholesterolemia 55 cervical intraepithelial neoplasia 55 Chronic pancreatitis 55 PI3K pathway 55 testicular tumors 55 cervical neoplasia 55 pegylated liposomal doxorubicin 55 chromosome #q# [002] 55 faulty BRCA genes 55 ano genital warts 55 HCV infections 55 neoplastic 55 DQB1 * 55 microsatellite instability 55 TMPRSS2 ERG fusion 55 transgenic mouse models 55 HLA DR 55 CETP gene 55 cirrhosis liver failure 55 metabolizing enzymes 55 HER2 positivity 55 myeloid leukemia 55 Radical prostatectomy 55 APOE allele 55 MiRNAs 55 goblet cells 55 IDH mutations 55 hepatic stellate cells 55 progesterone receptor negative 55 B7 H3 55 carcinoma HCC 55 Wnt signaling pathway 55 Atypical Hemolytic Uremic Syndrome 55 BMPR2 55 hemorrhagic strokes 55 Hepatocellular Carcinoma 55 atherothrombosis 55 prostate carcinogenesis 55 aldehyde dehydrogenase 55 Barrett esophagus 55 neoplasia 55 intracellular pathways 55 neurofibroma 55 atypical ductal hyperplasia 55 conditional logistic regression 55 cathepsins 55 mda 7 55 mitochondrial toxicity 55 C1q 55 IGF 1R 55 receptor tyrosine kinase inhibitor 55 teratoma 55 microscopic hematuria 55 pre cancerous 55 metastatic prostate